Correlation Between Avita Medical and Spero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avita Medical and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avita Medical and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avita Medical and Spero Therapeutics, you can compare the effects of market volatilities on Avita Medical and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avita Medical with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avita Medical and Spero Therapeutics.

Diversification Opportunities for Avita Medical and Spero Therapeutics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Avita and Spero is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Avita Medical and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Avita Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avita Medical are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Avita Medical i.e., Avita Medical and Spero Therapeutics go up and down completely randomly.

Pair Corralation between Avita Medical and Spero Therapeutics

Assuming the 90 days trading horizon Avita Medical is expected to under-perform the Spero Therapeutics. In addition to that, Avita Medical is 1.7 times more volatile than Spero Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Spero Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest  200.00  in Spero Therapeutics on September 6, 2025 and sell it today you would earn a total of  28.00  from holding Spero Therapeutics or generate 14.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Avita Medical  vs.  Spero Therapeutics

 Performance 
       Timeline  
Avita Medical 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Avita Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Spero Therapeutics 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Spero Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Spero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Avita Medical and Spero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avita Medical and Spero Therapeutics

The main advantage of trading using opposite Avita Medical and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avita Medical position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.
The idea behind Avita Medical and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk